IBAKE LIMITED

Company number 13106817 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

IBAKE LIMITED - Analysis Report

Company Number: 13106817

Analysis Date: 2025-07-29 20:19 UTC

Financial Health Assessment for IBAKE LIMITED (as of 31 December 2023)


1. Financial Health Score: D

Explanation:
The company shows significant signs of financial distress. While it is maintaining its legal and filing obligations on time, its core balance sheet metrics reveal troubling liquidity and working capital issues, reflected by persistent negative net current assets and a very small equity base. This places the company at a precarious financial position, requiring urgent attention.


2. Key Vital Signs

Metric Value (2023) Interpretation
Current Assets £12,994 Very low for a manufacturing business; insufficient for short-term obligations.
Cash at Bank £1,105 Critically low cash reserves; risky "cash flow pulse."
Debtors (Amounts owed by group) £11,889 Reliance on inter-company debts for liquidity; potentially illiquid.
Current Liabilities £62,244 Very high short-term debts; "symptom of strain."
Net Current Assets (Working Capital) -£49,250 Deeply negative working capital; "cash flow blockage" warning.
Total Assets Less Current Liabilities £1,000 Minimal net assets; very thin "financial skin."
Shareholders Funds (Equity) £1,000 Insufficient equity cushion; high financial risk.

Additional Observations:

  • The company's fixed asset investment (£50,250) is significant relative to net assets, but likely non-liquid and tied up in subsidiaries.
  • No employees reported, which may indicate limited operational activity or outsourcing.
  • The director holds 75-100% control, presenting concentrated ownership risk.
  • The company operates in the manufacturing of other food products (SIC 10890), a sector which usually requires steady working capital for inventory and production, but the company shows minimal current assets and high liabilities.

3. Diagnosis: What the Financial Data Reveals About Business Health

The financial "vital signs" of IBAKE LIMITED reveal symptoms consistent with a company under significant financial stress:

  • Liquidity Crisis: The company has very low cash reserves (£1,105) to meet immediate obligations (£62,244 in current liabilities), creating a "cash flow arrest" scenario.
  • Working Capital Deficiency: Negative net current assets (-£49,250) indicate the company cannot cover short-term debts with short-term assets, increasing risk of default or operational disruption.
  • Thin Equity Base: Shareholders’ funds stand at only £1,000, insufficient to absorb losses or support growth, akin to a patient with very low immunity.
  • Dependence on Group Debtors: A large portion of current assets is owed by group undertakings, which may not be readily collectible, further compromising liquidity.
  • No Reported Operational Staff: The absence of employees suggests a non-traditional manufacturing setup, possibly outsourcing or investment holding, but this limits operational flexibility.

Overall, the company’s financial health is fragile, with symptoms indicating potential solvency risks unless corrective measures are taken. Without intervention, the company’s "financial condition" could deteriorate further, potentially leading to insolvency.


4. Recommendations: Specific Actions to Improve Financial Wellness

Immediate (Short-Term) Interventions:

  • Enhance Cash Flow Management: Prioritize collection of debtors and reduce current liabilities through renegotiation of payment terms or seeking short-term financing to relieve liquidity constraints.
  • Review Inter-Company Balances: Evaluate the recoverability of amounts owed by group undertakings; consider restructuring or converting these into equity if possible.
  • Cost Control: Ensure minimal overheads and operational costs until liquidity improves.

Medium to Long-Term Strategies:

  • Capital Injection: Consider raising additional equity capital to strengthen shareholders’ funds and provide a buffer against losses.
  • Operational Review: Assess the business model, especially manufacturing operations, to ensure productive use of assets and improve profitability.
  • Debt Restructuring: Engage creditors to extend payment terms or restructure debt to sustainable levels, improving working capital.
  • Strategic Planning: Develop a clear business plan focusing on sustainable growth, profitability, and cash generation.

Monitoring:

  • Implement regular financial health checks focusing on liquidity ratios and working capital trends to detect early signs of distress.
  • Use forecasting tools to maintain a healthy "financial pulse" and avoid surprise cash shortfalls.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.